Atomo Diagnostics Company
Atomo Diagnostics design and manufactures blood-based, lateral flow rapid diagnostic test (RDT) devices.
Estimated Revenue:
$10M to $50M
Funding Status:
IPO
Industry:
Biotechnology, Health Care, Manufacturing, Medical Device
Last Funding Date:
2017-02-01
Technology:
P4 Medicine
Founded Date:
2010-01-01
Headquarters:
Leichhardt, New South Wales, Australia
Last Funding Type:
Convertible Note
Employee Number:
11-50